TNF and COVID-19: Additionally, the TNF inhibitor, tocilizumab has been approved as one of the treatment options available for multiple inflammatory diseases22–24 and in several previous studies, had shown to improve COVID-19 patients with respiratory symptoms in different populations globally25.